There is significant interest inILMN by institutional investors. The 95.82% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Biotechnology industry. Additionally, during the quarter ended December 2014, these large investors purchased a net $652.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 1.1 Million shares of Illumina Inc
AMERICAN CENTURY INVESTMENT MANA... Bought 532.7 Thousand shares of Illumina Inc
COLUMBIA MANAGEMENT INVESTMENT A... Bought 519.2 Thousand shares of Illumina Inc